Bacterial resistance to antimicrobial agents in Latin America - the giant is awakening

Página do item simplificado
dc.contributor.authorGuzman-Blanco, M.
dc.contributor.authorCasellas, J. M.
dc.contributor.authorSader, H. S.
dc.contributor.institutionCtr Med Caracas
dc.contributor.institutionHosp Vargas Caracas
dc.contributor.institutionSan Lucas Hosp
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T12:31:01Z
dc.date.available2016-01-24T12:31:01Z
dc.date.issued2000-03-01
dc.description.abstractResistant bacteria are emerging in Latin America as a real threat to the favorable outcome of infections in community- and hospital-acquired infections. Despite present extensive surveillance, healthcare workers who most need the information may be unaware of this growing problem. Outbreaks of meningococci with diminished susceptibility to penicillin have been reported in the region; a constant increase of resistance to penicillin in pneumococci and poor activity of commonly used oral antibiotics for the treatment of community-acquired urinary tract infections have made the treatment of these infections more difficult. Reports from tertiary hospitals are similar to many other areas of the world, with increasing frequency of Klebsiella pneumoniae-carrying extended-spectrum beta-lactamase, multiresistant strains of Pseudomonas aeruginosa and Acinetobacter baumanni in ICU settings, and reports of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. A surveillance network readily accessible to those who prescribe antibiotics in Latin America is highly desirable.en
dc.description.affiliationCtr Med Caracas, Caracas 1010, Venezuela
dc.description.affiliationHosp Vargas Caracas, Infect Dis & Microbiol Unit, Caracas, Venezuela
dc.description.affiliationSan Lucas Hosp, Infect Dis & Clin Microbiol Unit, Buenos Aires, DF, Argentina
dc.description.affiliationUniversidade Federal de São Paulo, Div Infect Dis, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Div Infect Dis, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent67-+
dc.identifierhttp://dx.doi.org/10.1016/S0891-5520(05)70218-X
dc.identifier.citationInfectious Disease Clinics of North America. Philadelphia: W B Saunders Co, v. 14, n. 1, p. 67-+, 2000.
dc.identifier.doi10.1016/S0891-5520(05)70218-X
dc.identifier.issn0891-5520
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/26260
dc.identifier.wosWOS:000086069700006
dc.language.isoeng
dc.publisherW B Saunders Co
dc.relation.ispartofInfectious Disease Clinics of North America
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.titleBacterial resistance to antimicrobial agents in Latin America - the giant is awakeningen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos